Embolic protection device enters US trial:
This article was originally published in Clinica
A multicentre clinical trial of Embolic Protection's filter for removing particles and blood clots during angioplasty and vascular interventions is underway in the US. The FilterWire EX is initially being assessed in 30 saphenous vein graft interventions, but a larger safety and efficacy trial is planned for early next year, says the Campbell, California company. The filter is attached to a 0.014 inch guidewire and can be inserted into a vessel through a 3F catheter. It allows blood to flow continuously through a vessel and can pass through much smaller arteries compared with other embolic protection devices, Milt McColl, Embolic's chief medical officer told Clinica.